Berkshire Hathaway to pay $ 9.7 billion for Oxicam, potentially Buffett’s last big deal
Our inbox sign up for free real time braking news alert sent directly to our braking news email Sign up on our free braking news email Sign up on our free braking news email Berkshire Hathaway The chemical division of oxidantal petroleum is purchasing for $ 9.7 billion, which may be the final major acquisition … Read more
